title: Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
authors.affiliation: Department of Surgery, Virchow Clinic, Humboldt University Berlin, Germany.
authors.forename: K P
authors.initials: KP
authors.lastname: Platz
authors.forename: S G
authors.initials: SG
authors.lastname: Tullius
authors.forename: A R
authors.initials: AR
authors.lastname: Mueller
authors.forename: G
authors.initials: G
authors.lastname: Schumacher
authors.forename: N
authors.initials: N
authors.lastname: Nüssler
authors.forename: R
authors.initials: R
authors.lastname: Neuhaus
authors.forename: W O
authors.initials: WO
authors.lastname: Bechstein
authors.forename: H
authors.initials: H
authors.lastname: Lobeck
authors.forename: P
authors.initials: P
authors.lastname: Neuhaus
mesh_terms: D000961:Antilymphocyte Serum / Q000627:therapeutic use; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D012086:Reoperation; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus